Knowledge and practice characteristics of pharmacists in Qatar towards medication use in pregnancy: a cross-sectional survey. by Rouf, Pallivalapilla Abdul et al.
  
 
AUTHOR(S): 
 
 
TITLE:  
 
 
YEAR:  
 
Publisher citation: 
 
 
 
OpenAIR citation: 
 
 
 
Publisher copyright statement: 
 
 
 
 
 
OpenAIR takedown statement: 
 
 This publication is made 
freely available under 
________ open access. 
 
 
 
 
 
This is the ______________________ version of an article originally published by ____________________________ 
in __________________________________________________________________________________________ 
(ISSN _________; eISSN __________). 
This publication is distributed under a CC ____________ license. 
____________________________________________________
 
Section 6 of the “Repository policy for OpenAIR @ RGU” (available from http://www.rgu.ac.uk/staff-and-current-
students/library/library-policies/repository-policies) provides guidance on the criteria under which RGU will 
consider withdrawing material from OpenAIR. If you believe that this item is subject to any of these criteria, or for 
any other reason should not be held on OpenAIR, then please contact openair-help@rgu.ac.uk with the details of 
the item and the nature of your complaint. 
 
Research article
137
EMHJ – Vol. 24 No. 2 – 2018
Knowledge and practice characteristics of pharmacists in Qatar 
towards medication use in pregnancy: a cross-sectional survey
Pallivalapilla Abdul Rouf1,, Binny Thomas1,2,3, Wessam Elkassem1,3, Asma Tarannum3, Doua Al Saad3, Mohammed M. Gasim3 and Moza Al Hail1,2,3
1Corporate Pharmacy, Hamad Medical Corporation, Doha, Qatar (Correspondence to: Binny Thomas: binnyinhmc@gmail.com; b.thomas1@rgu.ac.uk). 
2Robert Gordon University, Aberdeen, United Kingdom. 3Women’s Hospital, Hamad Medical Corporation, Doha, Qatar.
Introduction
Maternal health refers to the health of women pre-preg-
nancy, during pregnancy, childbirth and postpartum (1). 
Medication use during pregnancy is challenging be-
cause of the potential fetal risk associated with the use 
of medications. Given the maternal physiological chang-
es during pregnancy, women suffer from a variety of 
symptoms, such as nausea and vomiting, constipation, 
indigestion, hypertension, eclampsia and infections, for 
which medication use may be unavoidable at times (2). Al-
though a number of medications used during pregnancy 
are known to cause fetal harm, there is still a lack of data 
on the risk and safety of the vast majority of medications. 
Because of this, pregnant women might unknowingly 
take a medication that could affect her fetus, or the anx-
iety and overestimated risk perception may discourage 
women from adhering to beneficial regimens (3).
Medication use during pregnancy is common (2). 
Approximately 40% of all pregnancies worldwide are 
unplanned, representing about 85 million women (4), and 
most of these women have used medicines before their 
pregnancy is known. Global data suggest that 27% to 93% 
of all women use at least one prescription drug during 
pregnancy (5). A study in the United States of America 
(USA) found that in 88% of all pregnancies, women 
used at least one medication, either prescribed or over 
the counter (6). In Europe, the prevalence of prescribed 
medications during pregnancy varied considerably 
across countries, ranging from 26% in Serbia to 93% in 
France (7-9). In a recent study in Saudi Arabia, about 40% 
of all pregnant women were reported to have used either 
herbal or conventional medicines (10) while in Oman, a 
high prevalence in overall use of medications during 
pregnancy compared with the prepregnancy period was 
reported (11). No similar data have been published for 
Qatar.
Pharmacists are medication experts, well trained 
to apply evidence-based clinical knowledge, provide 
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pharmaceutical care and advise women on their 
prescriptions (12). Some patients approach pharmacists 
as the first step in seeking medical advice for their 
symptoms (13). Furthermore, studies have identified 
pharmacists as a primary health care provider in 
answering drug-related queries and counselling 
pregnant women on their medications (13,14). However, 
pharmacists may not have the information and skills to 
provide appropriate advice. A study in the USA, which 
explored pharmacists’ interpersonal skills and ability 
to propose appropriate therapeutic plans, reported that 
community pharmacist lacked appropriate knowledge 
and skills to provide pharmaceutical care (15). In a similar 
study in Saudi Arabia on awareness about drug safety and 
use of medications during pregnancy, more than 70% of 
pregnant women were confident about the information 
provided by pharmacists; however fewer than 18% had 
received any medication-related information from their 
pharmacists (16).
Pharmacy practice settings include pharmacy 
services in hospitals, polyclinics, primary health care 
services and community pharmacies (17). About 800 
licensed pharmacists were employed in Qatar in 2010 
(18). Dispensing of prescriptions remains the primary 
duty of pharmacists in Qatar, particularly in community 
pharmacies with no clinical pharmacy services. There 
are no mandatory instructions to provide patients with 
medication use information or counsel them on any new 
prescriptions.
Improvement of any health care services requires a 
clear understanding of the characteristics and knowledge 
of the health care workforce. As in other developing 
countries, pharmacy practice in Qatar is evolving rapidly; 
however, there is a lack of empirical evidence about 
pharmacists’ knowledge, practice and experience of 
drug use in pregnancy. Therefore, our research aimed 
to determine if the pharmacy workforce in Qatar was 
sufficiently trained and prepared to dispense medications 
to pregnant women.
The primary research objectives were to determine 
the knowledge, practice and confidence of pharmacists 
in Qatar about drug use in pregnancy. The secondary 
objectives was to determine the association between 
their knowledge, and their experience and continuing 
education.
Methods
Design and setting
A cross-sectional, descriptive, questionnaire-based study 
was conducted by the pharmacy department of the Wom-
en’s Hospital of the Hamad Medical Corporation from 
June to December 2010. All licensed pharmacists working 
in hospitals, community pharmacies, primary care cen-
tres and polyclinics were eligible for inclusion.
Sample size
A convenience sampling technique was used to recruit 
the pharmacists. Raosoft® online calculator was used to 
calculate the sample size (19). Based on this, a sample size 
of 300 pharmacists was required for a confidence level of 
95% and a 5% margin of error. However, 400 pharmacists 
were included in the final survey to add strength to the 
study and compensate for pharmacists failing to submit 
the questionnaire or submitting incomplete question-
naires.
Questionnaire
A 23-item self-completed anonymous questionnaire was 
developed and validated for the study. Most of the sur-
vey questions were adopted from previously validated 
surveys and tailored to meet the objectives of the current 
study (20-22). Previous questionnaire-based studies in 
Qatar have shown that surveys in English can be an effec-
tive tool to gather information from practising pharma-
cists in Qatar, even though the majority of pharmacists 
originate from Arabic-speaking countries (20,23). A group 
of expert pharmacists (drug information pharmacists, 
pharmacy supervisors, and senior community pharma-
cists) were consulted to evaluate the content validity of 
the questionnaire. A pilot study was conducted with 30 
pharmacists (16 community and 14 hospital pharmacists) 
and amendments were made wherever necessary.
The questionnaire had 4 sections.
 · Section 1: demographic and pharmacy practice char-
acteristics of the respondents (Q1−Q8), including age, 
gender, years of practice and participation in contin-
uing education.
 · Section 2: knowledge and perception of pharmacist 
about medication use during pregnancy (Q9−Q16). 
These questions had subdivisions giving a total of 28 
questions. In this section, pharmacists were asked 
about the most frequent medications dispensed, their 
concerns while dispensing medication to pregnant 
women, safety of medication during pregnancy and 
drugs causing fetal harm. The respondents’ knowl-
edge levels were assessed using scores: +1 for every 
correct answer and 0 for wrong answers.
 · Section 3: pharmacist’s level of confidence while deal-
ing with pregnant women, and physicians (Q17−Q20). 
This section mainly focused on how the participants 
identified pregnant women, how confident they were 
to advise them on medications and their confidence 
in contacting the prescribers (the woman’s physi-
cian).
 · Section 4: source of the drug information used (Q21−
Q23). This section identified the source of the drug 
information they provided while dispensing medica-
tion to pregnant women.
Data collection
A database was created of the 800 practising pharmacists 
in Qatar (both in the government and private sectors); 
the list of pharmacists was obtained from the licensing 
section of the Ministry of Public Health, Qatar. The ques-
tionnaire was distributed to 400 of these pharmacists.
Five pharmacists from the Women’s Hospital were 
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selected to distribute and collect the questionnaire 
(they were excluded from the study). Questionnaires 
were distributed personally to the pharmacists during 
the day shift. The pharmacy manager was also given 
questionnaires to give to any absentee pharmacists. 
Pharmacy technicians and pharmacists without a Qatari 
licence were excluded from the survey. Anonymously 
completed surveys were sent back to the principal 
investigator’s (PAR) office at the Women’s Hospital or 
collected from the drop box placed at every facility when 
the questionnaires were delivered, or were collected by a 
representative of the Women’s Hospital. Three reminders 
were sent at 10-day intervals by email/telephone, and a 
representative of the Women’s Hospital made frequent 
visits to all pharmacies. Several other strategies were used 
to maximize the response rate, including timely reminders 
to the managers to encourage their staff to complete the 
questionnaire, and sending the questionnaire to Hamad 
Medical Corporation hospitals with a cover letter and an 
addressed envelope to be returned through the internal 
mail system (24).
Data analysis
Descriptive statistics were used for all the variables. Data 
were analysed with SPSS, version 20. The knowledge lev-
el of each respondent was determined by ranking their 
answers based on a scale with a maximum score of 28 
(average knowledge for a score ≤ 15, good knowledge 
for a score of ≥ 16 to ≤ 24 and very good knowledge for a 
score of ≥ 25). To examine the association between knowl-
edge, and experience and continuing education, the chi-
squared test was used. A P-value ≤ 0.05 was considered 
statistically significant.
Ethical considerations
The study was approved by the Medical Research Center 
at Hamad Medical Corporation, MRC Protocol Number 
– MRC-10124.
Results
Of the 400 questionnaires distributed, 243 were returned 
in the 5-week collection period. Of these, 12 had not been 
filled and 24 were incomplete; these were excluded from 
the final analysis. Hence a total of 207 questionnaires 
were included in the final analysis (52% response rate), 
about 25% of the 800 licensed, practising pharmacist in 
Qatar at the time of the study.
Demographics and practice
The highest percentages of respondents were hospital 
pharmacists (46.9%), followed by community pharma-
cists (40.1%); only 13.0% responded from primary health 
care centres. About 50% of the pharmacists worked ≤ 40 
hours a week. The majority (95.7%) had a bachelor’s de-
gree in pharmacy; only 3% had completed a postgraduate 
degree (Table 1). Most pharmacists were non-Qataris.
Experience of pharmacists in Qatar
Most of the respondents (79.2%) had ≥ 5 years of expe-
rience as a registered pharmacist. However, when asked 
about dispensing medication to pregnant women, almost 
half of the respondents (48.3%) had less than a 10% work-
load in dispensing to pregnant women (Table 1).
Continuing pharmacy education
Over 50% of the pharmacists had less than 20 continuing 
pharmacy education credits or had received no contin-
uing education in past 12 months (Table 1). Lack of time 
and workload were cited as the main reasons for not 
attending these educational activities by 66% of the re-
spondents.
Dispensing to pregnant women
About three quarters (71%) of the respondents had not had 
any educational activities on medication use in pregnan-
cy during or after their Bachelor’s/Master’s pharmacy de-
gree. About three quarters (72%) considered that the best 
way to identify a pregnant patient was to have a pregnan-
cy status written on the prescription. The majority of the 
respondents (86%) were aware of the risks and benefits 
associated with medication use in pregnancy; about 80% 
stated that their work experience made them aware of 
the risk−benefits.
When asked how comfortable they were giving 
advice to pregnant women on medication, 66.2% were 
“very comfortable” to “somewhat comfortable”, 24.2% 
were neutral (neither comfortable nor uncomfortable) 
and 9.6% were uncomfortable. Their major concern while 
dispensing to pregnant women was not being aware of 
the stage of pregnancy (76.5%) (Figure 1).
Dispensed medications
The most frequently dispensed medications were vita-
mins and anti-emetics (> 95%); anti-epileptics, anti-lipi-
daemics, antidepressants and antipsychotics were the 
least dispensed (≤ 3%) (Table 2).
Knowledge levels of pharmacists in Qatar
Most of the respondents (64.7%) had average knowledge 
levels, while only a few (1%) had very good knowledge (i.e. 
respondents who scored more than 25/28 points).
Drug information resources used
Most of the respondents used the point of care referenc-
es. The most common drug information resources used 
by the pharmacists were the British National Formulary 
(77.8%), followed by Micromedex (52.3%) and Pregnancy 
specific books (32.3%) (Figure 2).
Knowledge and experience
Years of practice in Qatar significantly affected the phar-
macists’ knowledge levels. Approximately 60% of phar-
macists with 5−9 years of experience had good knowl-
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edge (scores ≥ 16 and ≤ 24), which was significantly 
higher than the pharmacists who had less than 5 years of 
experience (P < 0.001).
Knowledge and continuing pharmacy 
education
There was a significant correlation between knowledge 
and continuing education; about 60% of the pharmacists 
who had good knowledge had attended 40 or more hours 
of continuing educational activities in comparison with 
19% of the pharmacists who had no continuing pharmacy 
education points (P < 0.001).
Experience and continuing pharmacy 
education
During the first 5 years of employment, only 3.3% of phar-
macists had more than 40 continuing pharmacy educa-
tion points, whereas 56% of pharmacists with 5−9 years 
Table 1 Distribution of the pharmacist(s) by demographic and practice characteristics
Variable No. % (n = 207)
Gender
Male 114 55.1
Female 93 44.9
Practice
Hospital pharmacy 97 46.9
Primary health care 27 13.0
Community pharmacy 83 40.1
Place of practice
Women’s Hospital pharmacy 36 17.4
Al Amal Hospital pharmacy 8 3.9
Al Rumailah Hospital pharmacy 13 6.3
Hamad General Hospital pharmacy 33 15.9
Community pharmacies 73 35.3
Polyclinic 10 4.8
Primary health care centre 27 13.0
Al Khor Hospital pharmacy 7 3.4
Qualification
Bachelor’s degree 198 95.7
Master’s degree 8 3.9
Other (e.g. continuing pharmacy education) 1 0.5
Experience (years)
< 5 43 20.8
5–9 86 41.5
> 10 78 37.7
Hours per week
≤ 40 95 45.9
48 59 28.5
≥ 50 52 25.1
Dispensing workload to pregnant women (%)
< 10 100 48.3
1–20 38 18.4
> 20 52 25.1
Don’t know 17 8.2
Continuing pharmacy education (hours)
1–20 55 26.6
21–30 39 18.8
31–40 26 12.6
> 40 30 14.5
Noneª 57 27.5
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of experience had more than 40 continuing pharmacy 
education credits. However, about 44% of pharmacists 
with ≥ 10 years’ experience had no continuing pharmacy 
education credits (P < 0.001).
Confidence in giving information to patients 
and physicians
Only 33.3% of the respondents were very comfortable 
giving advice/counselling to pregnant women, however 
89% (strongly agreed and agreed) believed that they were 
competent enough to inform pregnant women about 
their medication. Similarly, about 81% [strongly agreed 
(30.9%) and agreed (50.2%)] of the respondents believed 
that they were competent enough to inform physicians 
about the risks and benefits of medications used in preg-
nancy.
There was no significant correlation between 
pharmacist’s length of experience and their confidence 
to inform patients about the risks and benefits of their 
medication; however with more experience they were 
more confident to inform physicians about risks and 
benefits (P = 0.38 and P < 0.001 respectively).
Discussion
A literature review of the past 10 years did not identify 
any similar studies from Qatar assessing the knowledge, 
experience, confidence and practice of pharmacist in Qa-
tar while dispensing medications to pregnant women.
The main findings of the study suggest that a majority 
of the respondents had an average level of knowledge 
about medications used during pregnancy. Most of 
the pharmacists had 5 or more years of experience; 
however, almost 50% of them had very little experience 
in dispensing medications to a pregnant woman. The 
study also showed that pharmacists in Qatar lacked 
participation in continuing education programmes. 
Although most of them felt confident to advise physicians 
on medications used in pregnancy, a good proportion 
was not comfortable about doing so for pregnant women.
The response rate was 52% and the highest percentage 
of respondents were hospital pharmacists, mostly from 
Hamad Medical Corporation. The response rate was in 
line to the results obtained from other pharmacist surveys 
in Qatar (20,22). The majority of the pharmacists had a 
bachelor’s degree in pharmacy, and most of them had 5 
or more years of working experience. For about half of 
the respondents less than 10% of their workload involved 
dispensing medications to pregnant women. This might 
be because most pregnant women are reviewed, treated 
and followed up at primary health care centres and the 
Women’s Hospital. Respondents for whom dispensing 
to pregnant women represented more than 20% of their 
workload were pharmacists at the Women’s Hospital.
Almost one third of the respondents had no 
continuing pharmacy education. More than 50% of the 
respondents stated that they had received less than 
20 hours of continuing educational sessions in a year. 
This result demonstrates the relevance and importance 
of continuing pharmacy educations sessions as an 
important area of pharmacy practice. The main reasons 
for not attending continuing pharmacy education were 
workload and the timing of the activities that were 
either during their busy working hours or on their off 
days. This result is similar to earlier studies done in 
Qatar and Saudi Arabia (25,26). Moreover, there were no 
obligatory continuous educational activities while this 
study took place. However, from 2015, the Qatar Council 
for Healthcare Practitioners mandated that every heath 
professional had to attend educational activities for the 
renewal of his/her practice licence (27).
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Figure 1 Major concerns expressed by pharmacists while dispensing medication to pregnant women
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In our evaluation of pharmacists’ knowledge about 
drug use in pregnancy, the majority of them had 
average knowledge. This might be because of the lack of 
continuing pharmacy education or the lack of experience 
in dispensing to pregnant women. Our result is similar 
to a study that compared knowledge levels among 
pharmacist in Qatar, Canada and Uganda (28).
The pharmacists preferred to identify a pregnant 
women based on the pregnancy status written on the 
prescription, although this is not a standard practice in 
Qatar, which should possibly alarm the hospital policy-
makers as specialized maternity hospitals like the 
Women’s Hospital require physicians to record pregnancy 
status on every prescription they write. The majority of 
the respondents felt able to assess the risk–benefit ratio 
while dispensing medication to pregnant women. The 
average level of knowledge of most pharmacists might be 
the reason why most were not very comfortable advising 
a pregnant woman on medication. Similar findings 
were reported from Tanzania (29). As, globally, 40% of 
pregnancies are unplanned (4), a woman often discovers 
her pregnancy while taking regular medications and may 
visit a pharmacy to enquire if she has harmed her baby 
by this action. A pharmacist is therefore expected to have 
sound knowledge about drugs to be used in pregnancy. 
However, despite the recognized role of pharmacists as 
medication experts, studies have shown that they lack 
knowledge and confidence while advising pregnant 
women (12,30).
Furthermore, researchers have highlighted the 
importance of continuing pharmacy educational 
programmes (22,28,31). As demonstrated in our study, 
of the pharmacists who had good knowledge, 60% had 
had more than 40 hours of continuing education in 
a year. This shows a significant positive association 
between continuing education and knowledge. Similarly, 
pharmacists with 5 or more years of experience scored 
better than those with less experience. Our study 
calls for structured continuing pharmacy educational 
programmes to be introduced in Qatar to ensure that 
pharmacists have the necessary updated information, 
education and skills to provide competent pharmaceutical 
care.
There were some limitations to our study and hence 
the results should be interpreted with caution. Despite 
all the strategies used to maximize participation, the 
response rate was low (52%). The reasons for non-
participation are unknown, although we think it may 
be because of the length of the survey, or lack of interest 
or time. The questionnaire was distributed only during 
the day shift and it is possible that pharmacists who 
completed it could have had a better understanding, 
knowledge and confidence about drug use in pregnancy 
Table 2 Pharmacist’s response to most commonly dispensed 
medication to pregnant women
Which of these medications do you 
dispense most frequently? 
No. (%)
(n = 207)
Analgesics 149 (72.0)
Antacids 185 (89.4)
Antimicrobials 54 (26.1)
Antidepressants 13 (6.3)
Antidiabetics 45 (21.7)
Antiemetics 198 (95.7)
Laxatives 139 (67.1)
Antihypertensive 52 (25.1)
Antiepileptics 4 (1.9)
Insulin 63 (30.4)
Antihistamines 64 (30.9)
Antiasthmatics 23 (11.1)
Antilipidemic 6 (2.9)
Antipsychotics 5 (2.4)
Vitamins 200 (96.6)
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Figure 2 Resources used by pharmacists to answer drug information for pregnant women
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Connaissances et caractéristiques des pratiques des pharmaciens qataris en matière 
d’utilisation des médicaments pendant la grossesse : étude transversale
Résumé
Contexte : L’utilisation des médicaments durant la grossesse est courante. Les pharmaciens jouent un rôle important 
dans l’amélioration de l’utilisation des médicaments pendant cette période Les données empiriques manquent sur les 
connaissances des pharmaciens et leurs pratiques en la matière.
Objectifs : La présente étude visait à déterminer les connaissances et les caractéristiques des pratiques des pharmaciens 
qataris en matière d’utilisation des médicaments pendant la grossesse.
Méthodes : Une étude transversale, reposant sur un questionnaire, a été conduite sur une période de six mois en 2010. 
Des questionnaires ont été distribués à 400 des 800 pharmaciens agréés exerçant au Qatar (dans les secteurs public et 
privé). Des données ont été recueillies sur les caractéristiques démographiques et concernant la pratique des pharmaciens, 
sur leurs connaissances et leur perception de l’utilisation des médicaments pendant la grossesse, sur leur confiance 
lorsqu’ils s’occupent de femmes enceintes et contactent les médecins prescripteurs, et sur les sources des informations 
qu’ils détenaient sur les médicaments.
Résultats : Sur les 400 questionnaires distribués, 207 ont été renvoyés (taux de réponse de 52 %). La plupart des 
pharmaciens (71 %) n’avaient jamais participé à aucune activité de formation sur l’utilisation des médicaments pendant la 
grossesse. Environ 50 % ont rapporté que moins de 10 % de leur charge de travail impliquait la délivrance de médicaments 
aux femmes enceintes. Un manque de ressources disponibles et l’ignorance de l’état de grossesse des clientes étaient 
les principales préoccupations liées à la délivrance de médicaments aux femmes enceintes. La majorité des répondants 
avaient une connaissance moyenne de l’utilisation des médicaments pendant la grossesse. Il existait une association 
significative entre les connaissances, la formation continue et les années d’expérience (p < 0,05).
Conclusions : Les pharmaciens qataris avaient un degré de connaissance moyen de l’utilisation des médicaments pendant 
la grossesse. Des programmes de formation continue sont requis pour les pharmaciens qataris de façon à améliorer leurs 
connaissances et leurs pratiques en matière d’utilisation des médicaments pendant la grossesse.
than pharmacists in other shifts (response bias). 
Furthermore, there is a potential for social desirability 
bias since the findings are based on self-reports. The 
survey was completed on hard copy and there is a 
possibility of information exchange between the 
respondents while answering the knowledge questions. 
Although the demographics of our sample were similar 
to the total pharmacist population, the findings may 
not be generalizable in terms of knowledge because 
Women’s Hospital respondents have specialized training 
in maternity medication use and might therefore have 
scored much higher on the knowledge questions than 
other pharmacists.
Conclusion
The study provides baseline data on the knowledge, 
practice characteristics and experience of pharmacists 
in Qatar about medication use in pregnancy. Although it 
was conducted in 2007 and changes may have occurred, 
medication use during pregnancy is prevalent and there 
is still a lack of data on the knowledge, attitude and prac-
tice of pharmacists in Qatar towards medication use in 
pregnancy. To the best of our knowledge, no similar stud-
ies have been published in the region to date. With the 
majority of respondents having an average knowledge 
and lacking continuous educational activities, there is a 
need to introduce continuous education programmes to 
fill knowledge gaps of pharmacists on medications used 
in pregnancy. Our study in fact led to several continuing 
professional development activities on medication use 
during pregnancy, accredited by the Qatar Council of 
HealthCare Practitioners (official body for accrediting 
continuing professional development providers in Qa-
tar). Our study also highlights the importance of over-
coming several other obstacles faced by pharmacists in 
Qatar while giving drug information to pregnant wom-
en, such as lack of time and lack of training in drugs used 
during pregnancy. As women take different medications 
during pregnancy, both prescription and over-the-coun-
ter drugs, including complementary and traditional med-
ications, it is important to understand their knowledge 
about the use of such products in pregnancy. Therefore, 
further research is needed to identify the attitude, per-
ception and knowledge of pregnant women themselves 
about the medications they use during pregnancy.
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يعطقم نايبتسا :لملحا ءانثأ ةيودلأا مادختسا نأشب متهاسرمامب ةصالخا تماسلاو رطق في ةلدايصلا تامولعم
ليلها ةزوم ،مساقلا دوممح ،دعسلا ءاعد ،مننرات ءماسأ ،مساقلا ماسو ،ساموت ينيب ،فوؤرلا دبع لايبلاافيلاب
ةصلالخا
 عيملج هتحاتإو يحصلا ءاذغلا يرفوت لمشت نأ يوذغتلاو يئاذغلا نملأاب ةينعلما ةيموكلحا جمابرلاو تاسايسلا عيملج يغبني :ةيساسلأا تامولعلما
.ةلوقعم راعسأب سانلا
 لىع ةيبيرتج ينهارب دجوت لاو .لملحا ءانثأ ةيودلأا مادختسا ينستح في مهم رودب ةلدايصلا علطضيو .لملحا ءانثأ ةيودلأا مادختسا عيشي :ةيفللخا
.رطق في لملحا ءانثأ ةيودلأا مادختسا نأشب متهابرخو متهاسراممو ةلدايصلا تامولعم
.لملحا ءانثأ ةيودلأا مادختسا نأشب متهاسرمامب ةصالخا تماسلاو رطق في ةلدايصلا تامولعم ديدتح لىإ ةساردلا هذه تفده :فادهلأا
 لصأ نم نيلاديص 400 لىع تانايبتسلاا عيزوت متو .2010 ماع في رهشأ 6 ةترف للاخ نايبتسا ساسأ لىع ةيعطقم ةسارد تيرجُأ :ثحبلا قرط
 ؛متهاسرامم تماسو ةلدايصلل ةيناكسلا تماسلا :لوح تانايب تعُجو .)صالخاو يموكلحا ينعاطقلا في( رطق في لمعلاب مله حصرم نيلاديص 800
 .يرقاقعلا نع متهامولعم رداصمو ؛ءابطلأاو لماولحا عم لماعتلا في مهتقثو ؛لملحا ءانثأ ةيودلأا مادختسا نأشب متهاروصتو متهامولعمو
 لم )%71( ةلدايصلا بلغأ نأ ّينبتو .)%52 ةباجتسا لدعمب( مهنم 207 لىع درلا مت ،ًانايبتسا 400 اهددع غلابلا ةعزولما تانايبتسلاا نم :جئاتنلا
 ةيودأ فصر نمضتي مهلمع ءبع نم %10 نم لقأ نأب مهنم %50 وحن دافأو .لملحا ءانثأ ةيودلأا مادختسا نأشب ةيميلعت ةطشنأ يأ في اوكراشي
 مظعم نأ ينبت ماك .لملحا عضوب ةفرعلما مدعو ةحاتلما دراولما ةيافك مدع في لماوحلل ةيودلأا فصرب ةقلعتلما ةيسيئرلا فواخلما تلثتمو .لماوحلل
 ةبرلخا تاونسو رمتسلما ميلعتلاو تامولعلما ينب قيثو طابترا ل ِّجُسو .لملحا ءانثأ ةيودلأا مادختسا نأشب ةطسوتم ةفرعم ميهدل تناك ينبيجتسلما
.)P <0.05(
 ةلدايصلل رمتسم ميلعت جمارب دقع مزلي ،مث نمو .لملحا ءانثأ ةيودلأا مادختسا نأشب طسوتم ةفرعم ىوتسمب رطق في ةلدايصلا عتمتي :تاجاتنتسلاا
 .لملحا ءانثأ ةيودلأا مادختساب قلعتي مايف متهاسراممو متهامولعم ينستح لجأ نم رطق في
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